Long-range enhancers on 8q24 regulate c-Myc

Proceedings of the National Academy of Sciences of the United States of America

Volumn 107, Issue 7, 2010, Pages 3001-3005

  Sotelo, Jose ^a   Esposito, Dominic ^a   Duhagon, Maria Ana ^a   Banfeld, Kelley ^a   Mehalko, Jennifer ^a   Liao, Hongling ^a,b   Stephens, Robert M ^a,b   Harris, Timothy J R ^a   Munroe, David J ^a   Wu, Xiaolin ^a  

^a NATIONAL CANCER INSTITUTE   (United States)

^b SAIC FREDERICK INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA CATENIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR TCF 4; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CHROMOSOME 8Q; COLON CANCER; ENHANCER REGION; GENE EXPRESSION REGULATION; GENE INTERACTION; HUMAN; ONCOGENE C MYC; PRIORITY JOURNAL; PROSTATE CANCER; SINGLE NUCLEOTIDE POLYMORPHISM; TRANSCRIPTION REGULATION;

BASE SEQUENCE; BASIC HELIX-LOOP-HELIX LEUCINE ZIPPER TRANSCRIPTION FACTORS; BETA CATENIN; CHROMATIN IMMUNOPRECIPITATION; CHROMOSOMES, HUMAN, PAIR 8; COMPUTATIONAL BIOLOGY; DNA PRIMERS; ENHANCER ELEMENTS, GENETIC; GENE EXPRESSION REGULATION; GENETIC PREDISPOSITION TO DISEASE; HUMANS; LUCIFERASES; MOLECULAR SEQUENCE DATA; NEOPLASMS; PROTO-ONCOGENE PROTEINS C-MYC; TRANSCRIPTION FACTORS;

EID: 77649263411     PISSN: 00278424     EISSN: 10916490     Source Type: Journal    
DOI: 10.1073/pnas.0906067107     Document Type: Article

References (33)

1. Cher ML, et al. (1996) Genetic alterations in untreated metastases and androgen-independent prostate cancer detected by comparative genomic hybridization and allelotyping. Cancer Res 56:3091-3102.
2. Visakorpi T, et al. (1995) Genetic changes in primary and recurrent prostate cancer by comparative genomic hybridization. Cancer Res 55:342-347.
3. Korsmeyer SJ (1992) Chromosomal translocations in lymphoid malignancies reveal novel proto-oncogenes. Annu Rev Immunol 10:785-807.
4. Douglas EJ, et al. (2004) Array comparative genomic hybridization analysis of colorectal cancer cell lines and primary carcinomas. Cancer Res 64:4817-4825.
5. Ribeiro FR, et al. (2006) 8q gain is an independent predictor of poor survival in diagnostic needle biopsies from prostate cancer suspects. Clin Cancer Res 12: 3961-3970.
6. Ried T, et al. (1996) Comparative genomic hybridization reveals a speci.c pattern of chromosomal gains and losses during the genesis of colorectal tumors. Genes Chromosomes Cancer 15:234-245.
7. Yeager M, et al. (2007) Genome-wide association study of prostate cancer identifies a second risk locus at 8q24. Nat Genet 39:645-649.
8. Amundadottir LT, et al. (2006) A common variant associated with prostate cancer in European and African populations. Nat Genet 38:652-658.
9. Gudmundsson J, et al. (2007) Genome-wide association study identi.es a second prostate cancer susceptibility variant at 8q24. Nat Genet 39:631-637.
10. Haiman CA, et al. (2007) Multiple regions within 8q24 independently affect risk for prostate cancer. Nat Genet 39:638-644.
11. Freedman ML, et al. (2006) Admixture mapping identifies 8q24 as a prostate cancer risk locus in African-American men. Proc Natl Acad Sci USA 103:14068-14073.
12. Tomlinson I, et al.; CORGI Consortium (2007) A genome-wide association scan of tag SNPs identi.es a susceptibility variant for colorectal cancer at 8q24.21. Nat Genet 39: 984-988.
13. Zanke BW, et al. (2007) Genome-wide association scan identi.es a colorectal cancer susceptibility locus on chromosome 8q24. Nat Genet 39:989-994.
14. Haiman CA, et al. (2007) A common genetic risk factor for colorectal and prostate cancer. Nat Genet 39:954-956.
15. Witte JS (2007) Multiple prostate cancer risk variants on 8q24. Nat Genet 39:579-580.
16. Easton DF, et al.; SEARCH collaborators; kConFab; AOCS Management Group (2007) Genome-wide association study identifies novel breast cancer susceptibility loci. Nature 447:1087-1093.
17. Dekker J, Rippe K, Dekker M, Kleckner N (2002) Capturing chromosome conformation. Science 295:1306-1311.
18. Nobrega MA, Ovcharenko I, Afzal V, Rubin EM (2003) Scanning human gene deserts for long-range enhancers. Science 302:413.
19. Qin Y, et al. (2004) Long-range activation of Sox9 in Odd Sex (Ods) mice. Hum Mol Genet 13:1213-1218.
20. Lavenu A, Pournin S, Babinet C, Morello D (1994) The cis-acting elements known to regulate c-myc expression ex vivo are not sufficient for correct transcription in vivo. Oncogene 9:527-536.
21. Hallikas O, et al. (2006) Genome-wide prediction of mammalian enhancers based on analysis of transcription-factor binding af.nity. Cell 124:47-59.
22. Wierstra I, Alves J (2008) The c-myc promoter: Still MysterY and challenge. Adv Cancer Res 99:113-333.
23. Murphy DJ, et al. (2008) Distinct thresholds govern Myc's biological output in vivo. Cancer Cell 14:447-457.
24. Heintzman ND, et al. (2009) Histone modi.cations at human enhancers re.ect global cell-type-speci.c gene expression. Nature 459:108-112.
25. Hatzis P, et al. (2008) Genome-wide pattern of TCF7L2/TCF4 chromatin occupancy in colorectal cancer cells. Mol Cell Biol 28:2732-2744.
26. Geiger A, Salazar G, Le Cam A, Kervran A (2001) Characterization of an enhancer element in the proximal promoter of the mouse glucagon receptor gene. Biochim Biophys Acta 1517:236-242.
27. Stewart CL, Schuetze S, Vanek M, Wagner EF (1987) Expression of retroviral vectors in transgenic mice obtained by embryo infection. EMBO J 6:383-388.
28. Wagner EF, Vanek M, Vennström B (1985) Transfer of genes into embryonal carcinoma cells by retrovirus infection: ef.cient expression from an internal promoter. EMBO J 4: 663-666.
29. Liu J, Levens D (2006) Making myc. Curr Top Microbiol Immunol 302:1-32.
30. He TC, et al. (1998) Identi.cation of c-MYC as a target of the APC pathway. Science 281:1509-1512.
31. Korinek V, et al. (1997) Constitutive transcriptional activation by a beta-catenin-Tcf complex in APC-/- colon carcinoma. Science 275:1784-1787.
32. Lowe SW, Cepero E, Evan G (2004) Intrinsic tumour suppression. Nature 432:307-315.
33. Hagège H, et al. (2007) Quantitative analysis of chromosome conformation capture assays (3C-qPCR). Nat Protoc 2:1722-1733.